Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Pediatric Immunoinfectivology, |
RCV002463983 | SCV002758753 | uncertain significance | Immunodeficiency 15a | 2022-10-17 | criteria provided, single submitter | clinical testing | Patient suffered with recurrent and severe infections since early infancy and developed in adulthood a Rheumatoid Arthritis with poor response to several biological DMARDs. Immunology referral allowed a clinical diagnosis of Common Variable Immunodeficiency (CVID) not confirmed in her father carrying the same variant. Preliminary functional data indicated a delayed and reduced capacity of B lymphocytes and CD4 positive T cells in inducing IκBα degradation and p65 phosphorilation. Whether this patient’s functional deficiency is due to the underlying genetic defect or, alternatively, directly induced by Rituximab and other immunosuppressive treatments is a matter of concern. |